Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial-Reference-Cited by-同舟云学术

Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial

Published:2016-09-13 Issue:1 Volume:16 Page:
ISSN:1472-6882
Container-title:BMC Complementary and Alternative Medicine
language:en
Short-container-title:BMC Complement Altern Med

Author:

Cao Kegang,Han Fang,Lin Anji,Yang Wenming,Zhao Jianjun,Zhang Hui,Ding Yanbing,Xie Wei,Xu Yinping,Yu Tingmin,Wang Xinzhi,Yang Xiaosu,Zhou Jiying,Hou Qun,Yu Lihua,Gao Ying

Funder

Project of National Great New Drug Research and Development

the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Complementary and alternative medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12906-016-1321-8.pdf

Reference40 articles.

1. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders (beta version). Cephalalgia. 2013;33(9):629–808.

2. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2163–96.